Home
>
National Drug Code (NDC)
>
Fenofibric Acid
Fenofibric Acid - 0115-1460-10 - (Fenofibric Acid)
Drug Information of Fenofibric Acid
| Product NDC: | 0115-1460 |
| Proprietary Name: | Fenofibric Acid |
| Non Proprietary Name: | Fenofibric Acid |
| Active Ingredient(s): | 135 mg/1 & nbsp; Fenofibric Acid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fenofibric Acid
| Product NDC: | 0115-1460 |
| Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022224 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20081215 |
Package Information of Fenofibric Acid
| Package NDC: | 0115-1460-10 |
| Package Description: | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0115-1460-10) |
NDC Information of Fenofibric Acid
| NDC Code | 0115-1460-10 |
| Proprietary Name | Fenofibric Acid |
| Package Description | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0115-1460-10) |
| Product NDC | 0115-1460 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fenofibric Acid |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20081215 |
| Marketing Category Name | NDA |
| Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Substance Name | FENOFIBRIC ACID |
| Strength Number | 135 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
